Cart Details

VAXNEUVANCE SYG 0.5ML

  • Manufacturer Name : Merck
  • MFG # : 00006432902
  • NDC : 00006432902
  • Distributor Name : AmeriSource Bergen
PID UOM Price Qty

This product is not currently available, please contact us for further information.

Register For Member Price

 

Product Properties:

Description Pneumococcal vacc 15 val im, 0.5 ML
Description -
Description -
DESI Drug Ind -; -
DESI Drug Ind -; -
DESI Drug Ind -
DESI2 Drug Ind -
Drug Category -
Drug Category USES: This vaccine is used to help protect from infection due to a certain bacteria (Streptococcus pneumoniae). This bacteria can cause ear infection or other more serious infections (such as pneumonia, meningitis). Some brands are approved for use only in children, while others can be used in both children and adults. Vaccines may not fully protect everyone who receives them.
Drug Category USES: This vaccine is used to help protect from infection due to a certain bacteria (Streptococcus pneumoniae). This bacteria can cause ear infection or other more serious infections (such as pneumonia, meningitis). Some brands are approved for use only in children, while others can be used in both children and adults. Vaccines may not fully protect everyone who receives them.
Drug Type Code COMMON BRAND NAME(S): Prevnar 13, Prevnar 20
Drug Type Code COMMON BRAND NAME(S): Prevnar 13, Prevnar 20
Drug Type Code -
FDA Approval Date -
FDA Therap Equiv -
HCPCS 90671
HCPCS -
HCPCS -
Market Entry Date -
Medical Coverage COVERAGE INFORMATION NOT AVAILABLE
Medical Coverage -
Medical Coverage -
Termination Date (NEU-mo-KOK-al KON-jih-gut)
Termination Date (NEU-mo-KOK-al KON-jih-gut)
Termination Date -
Unit -
Units Per Pkg -
Active Ingredients 18828 pneumococcal 15-valent conjugate to diphtheria crm; 9870 preservative free
Active Ingredients 18828 pneumococcal 15-valent conjugate to diphtheria crm; 9870 preservative free
Active Ingredients 18828 pneumococcal 15-valent conjugate to diphtheria crm; 9870 preservative free
AHFS Class 80120000 VACCINES
AHFS Class 80120000 VACCINES
AHFS Class 80120000 VACCINES
DEA Class NC
DEA Class NC
DEA Class NC
Dose Form SYRINGE (ML)
Dose Form SYRINGE (ML)
Dose Form SYRINGE (ML)
Fine Line Class 850085008510 All Rx Products
Fine Line Class 850085008510 All Rx Products
Fine Line Class 850085008510 All Rx Products
Gen Code and Des 82576 pneumoc 15-val conj-Dip crm/PF INTRAMUSC SYRINGE 0.5 ML
Gen Code and Des 82576 pneumoc 15-val conj-Dip crm/PF INTRAMUSC SYRINGE 0.5 ML
Gen Code and Des 82576 pneumoc 15-val conj-Dip crm/PF INTRAMUSC SYRINGE 0.5 ML
Inactive Ingredients 2551 polysorbates 9005645
Inactive Ingredients 2551 polysorbates 9005645
Inactive Ingredients 2551 polysorbates 9005645
OMP Family -
OMP Family -
OMP Family -
Product Category RX Pharmaceuticals
Product Category RX Pharmaceuticals
Product Category RX Pharmaceuticals
Strength -
Strength -
Strength -
Common Brand Name 90671
Common Brand Name COMMON BRAND NAME(S): Prevnar 13, Prevnar 20
Common Brand Name 90671
Drug Interaction -
Drug Interaction -
Drug Interaction DRUG INTERACTIONS: Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your health care professional. Do not start, stop, or change the dosage of any medicines without your doctor's approval. Some products that may interact with this vaccine include: drugs that weaken the immune system (including cyclosporine, tacrolimus, cancer chemotherapy, corticosteroids such as prednisone).
Allocation Period -
Allocation Period -
Allocation Period -
Case Quantity 112
Case Quantity 112
Case Quantity 112
Drug Form Pack Size -
Drug Form Pack Size -
Drug Form Pack Size -
Form SYRINGE
Form SYRINGE
Form SYRINGE
Hazard Code -
Hazard Code -
Hazard Code -
Listed Chemical -
Listed Chemical -
Listed Chemical -
NIOSH Code -
NIOSH Code -
NIOSH Code -
Orange Book ZB Particular pharmaceutical entity was not evaluated.
Orange Book ZB Particular pharmaceutical entity was not evaluated.
Orange Book ZB Particular pharmaceutical entity was not evaluated.
Retail Pack Quantity 1
Retail Pack Quantity 1
Retail Pack Quantity 1
Returnable Status Returnable
Returnable Status Returnable
Returnable Status Returnable
Special Storage Cond 00 None
Special Storage Cond 00 None
Special Storage Cond 00 None
Temp Zone 30 Refrige./DoNot Freez
Temp Zone 30 Refrige./DoNot Freez
Temp Zone 30 Refrige./DoNot Freez
Unit EA
Unit EA
Unit EA
Unit Size 0.5
Unit Size 0.5
Unit Size 0.5
How to Use HOW TO USE: Read all vaccine information available from your health care professional before receiving the vaccine. If you have any questions, ask your health care professional. This vaccine is injected into a muscle by a health care professional. It is usually injected into the thigh in infants or into the upper arm in toddlers, children, and adults. The child may receive up to 4 injections. The number of injections that are given depends on the age of the child. Adults only receive 1 injection. If the child is receiving this vaccination before spleen surgery or before receiving cancer chemotherapy or other drugs that decrease the immune system function, it should be given at least 2 weeks before these procedures to be effective. Talk to your health care professional for more information.
How to Use -
How to Use -
Missed Dose -
Missed Dose -
Missed Dose MISSED DOSE: It is important to receive each vaccination as scheduled. Be sure to ask when each dose should be received and make a note of the schedule.
Notes NOTES: It is important to understand the risks and benefits of vaccinations. Discuss this with your health care professional. Talk to your health care professional about the need for other vaccines to prevent possibly severe illness (such as flu shots). Make sure all of your health care professionals know you have received this vaccine. Make sure a note is placed in your medical record of having received this vaccine.
Notes -
Notes -
Overdose -
Overdose -
Overdose OVERDOSE: Not applicable.
Phonetic Pronunciation COVERAGE INFORMATION NOT AVAILABLE
Phonetic Pronunciation COVERAGE INFORMATION NOT AVAILABLE
Phonetic Pronunciation (NEU-mo-KOK-al KON-jih-gut)
Precautions -
Precautions PRECAUTIONS: Before receiving this vaccine, tell your health care professional if you are allergic to it; or to other vaccines (such as diphtheria, tetanus, Haemophilus influenzae); or if you have any other allergies. This product may contain inactive ingredients (such as latex or dry natural rubber that can be found in the product packaging), which can cause allergic reactions or other problems. Talk to your health care professional for more details. Before using this vaccine, tell your health care professional your medical history, especially of: vaccination/immunization history, recent illness/fever, immune system disorders (such as due to HIV infection, certain cancers such as leukemia/lymphoma, cancer or radiation treatment). During pregnancy, this vaccine should be used only when clearly needed. Discuss the risks and benefits with your health care professional. It is unknown if this vaccine passes into breast milk. Consult your health care professional before breast-feeding.
Precautions -
Side Effects -
Side Effects SIDE EFFECTS: Injection site reactions (such as pain, redness, swelling, hard lump), muscle/joint aches, or fever may occur. Ask your health care professional about taking a fever/pain reducer (such as acetaminophen) to help treat these symptoms. Drowsiness, tiredness, headache, irritability, loss of appetite, nausea, or diarrhea may also occur. If any of these effects last or get worse, tell your health care professional promptly. Rarely, some people have symptoms such as fainting, dizziness, vision changes, or ringing in the ears just after getting a vaccine injection. Tell your health care professional right away if you have any of these symptoms. Sitting or lying down may help, since these symptoms usually don't last long. Remember that this medication has been prescribed because your health care professional has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. Get medical help right away if you have any very serious side effects, including: seizures. A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your health care professional. Contact the health care professional for medical advice about side effects. The following numbers do not provide medical advice, but in the US you may report side effects to the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967. In Canada, you may call the Vaccine Safety Section at Public Health Agency of Canada at 1-866-844-0018.
Side Effects -
Storage -
Storage STORAGE: Store in the refrigerator. Do not freeze. Keep all medications away from children and pets. Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed. Consult your pharmacist or local waste disposal company.
Storage -
Uses Pneumococcal vacc 15 val im, 0.5 ML
Uses USES: This vaccine is used to help protect from infection due to a certain bacteria (Streptococcus pneumoniae). This bacteria can cause ear infection or other more serious infections (such as pneumonia, meningitis). Some brands are approved for use only in children, while others can be used in both children and adults. Vaccines may not fully protect everyone who receives them.
Uses Pneumococcal vacc 15 val im, 0.5 ML

Frequently Asked Questions(FAQs)

The cost of VAXNEUVANCE SYG 0.5ML is available for registerd members only .
VAXNEUVANCE SYG 0.5ML is manufactured by Merck.
Read More

Subscribe to Our Newsletter